ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Feb 23, 2017
Insider Transaction Report
Form 4
Moore Terrence O
EVP, CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2017-02-21$34.45/sh+7,856$270,639→ 9,527 total - Exercise/Conversion
Stock Option (right to buy)
2017-02-21−7,856→ 82,500 totalExercise: $34.45Exp: 2025-03-19→ Common Stock (7,856 underlying) - Sale
Common Stock
2017-02-21$39.65/sh−7,856$311,490→ 1,671 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015, as amended in June 2016. All sales under the trading plan have been completed.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on March 20, 2016. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.